vs
爱齐科技（ALGN）与SELECT MEDICAL HOLDINGS CORP（SEM）财务数据对比。点击上方公司名可切换其他公司
SELECT MEDICAL HOLDINGS CORP的季度营收约是爱齐科技的1.3倍（$1.4B vs $1.0B）。爱齐科技净利率更高（13.0% vs 1.4%，领先11.5%）。SELECT MEDICAL HOLDINGS CORP同比增速更快（6.4% vs 5.3%）。爱齐科技自由现金流更多（$187.3M vs $5.2M）。过去两年SELECT MEDICAL HOLDINGS CORP的营收复合增速更高（2.8% vs 2.5%）
爱齐科技是一家全球知名医疗设备企业，主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务，客户覆盖正畸医师、全科牙医，面向修复、美容牙科领域，业务分为透明矫治器、扫描仪及服务两大板块，可满足青少年等不同群体的正畸需求
Select Medical是总部位于美国宾夕法尼亚州的医疗健康企业，业务涵盖长期急症护理、住院康复医院运营，同时开设有职业健康与物理治疗诊所，母公司Select Medical Holdings在纽约证券交易所挂牌上市。
ALGN vs SEM — 直观对比
营收规模更大
SEM
是对方的1.3倍
$1.0B
营收增速更快
SEM
高出1.1%
5.3%
净利率更高
ALGN
高出11.5%
1.4%
自由现金流更多
ALGN
多$182.0M
$5.2M
两年增速更快
SEM
近两年复合增速
2.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.4B |
| 净利润 | $135.8M | $20.2M |
| 毛利率 | 65.3% | — |
| 营业利润率 | 14.8% | 4.6% |
| 净利率 | 13.0% | 1.4% |
| 营收同比 | 5.3% | 6.4% |
| 净利润同比 | 30.8% | 225.7% |
| 每股收益（稀释后） | $1.88 | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGNSEM
| Q4 25 | $1.0B | $1.4B | ||
| Q3 25 | $995.7M | $1.4B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $979.3M | $1.4B | ||
| Q4 24 | $995.2M | $1.3B | ||
| Q3 24 | $977.9M | $1.3B | ||
| Q2 24 | $1.0B | $1.3B | ||
| Q1 24 | $997.4M | $1.3B |
净利润ALGNSEM
| Q4 25 | $135.8M | $20.2M | ||
| Q3 25 | $56.8M | $28.8M | ||
| Q2 25 | $124.6M | $40.6M | ||
| Q1 25 | $93.2M | $56.7M | ||
| Q4 24 | $103.8M | $-16.1M | ||
| Q3 24 | $116.0M | $55.6M | ||
| Q2 24 | $96.6M | $77.6M | ||
| Q1 24 | $105.0M | $96.9M |
毛利率ALGNSEM
| Q4 25 | 65.3% | — | ||
| Q3 25 | 64.2% | — | ||
| Q2 25 | 69.9% | — | ||
| Q1 25 | 69.5% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 69.7% | — | ||
| Q2 24 | 70.3% | — | ||
| Q1 24 | 70.0% | — |
营业利润率ALGNSEM
| Q4 25 | 14.8% | 4.6% | ||
| Q3 25 | 9.7% | 5.4% | ||
| Q2 25 | 16.1% | 6.5% | ||
| Q1 25 | 13.4% | 8.3% | ||
| Q4 24 | 14.5% | 1.6% | ||
| Q3 24 | 16.6% | 4.3% | ||
| Q2 24 | 14.3% | 5.8% | ||
| Q1 24 | 15.5% | 9.0% |
净利率ALGNSEM
| Q4 25 | 13.0% | 1.4% | ||
| Q3 25 | 5.7% | 2.1% | ||
| Q2 25 | 12.3% | 3.0% | ||
| Q1 25 | 9.5% | 4.2% | ||
| Q4 24 | 10.4% | -1.2% | ||
| Q3 24 | 11.9% | 4.4% | ||
| Q2 24 | 9.4% | 6.1% | ||
| Q1 24 | 10.5% | 7.3% |
每股收益（稀释后）ALGNSEM
| Q4 25 | $1.88 | $0.17 | ||
| Q3 25 | $0.78 | $0.23 | ||
| Q2 25 | $1.72 | $0.32 | ||
| Q1 25 | $1.27 | $0.44 | ||
| Q4 24 | $1.40 | $-0.12 | ||
| Q3 24 | $1.55 | $0.43 | ||
| Q2 24 | $1.28 | $0.60 | ||
| Q1 24 | $1.39 | $0.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $26.5M |
| 总债务越低越好 | — | $1.8B |
| 股东权益账面价值 | $4.0B | $1.7B |
| 总资产 | $6.2B | $5.9B |
| 负债/权益比越低杠杆越低 | — | 1.06× |
8季度趋势，按日历期对齐
现金及短期投资ALGNSEM
| Q4 25 | $1.1B | $26.5M | ||
| Q3 25 | $1.0B | $60.1M | ||
| Q2 25 | $901.2M | $52.3M | ||
| Q1 25 | $873.0M | $53.2M | ||
| Q4 24 | $1.0B | $59.7M | ||
| Q3 24 | $1.0B | $191.5M | ||
| Q2 24 | $761.4M | $111.2M | ||
| Q1 24 | $865.8M | $92.6M |
总债务ALGNSEM
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.8B |
股东权益ALGNSEM
| Q4 25 | $4.0B | $1.7B | ||
| Q3 25 | $4.0B | $1.7B | ||
| Q2 25 | $3.9B | $1.7B | ||
| Q1 25 | $3.8B | $1.7B | ||
| Q4 24 | $3.9B | $1.7B | ||
| Q3 24 | $3.9B | $1.9B | ||
| Q2 24 | $3.8B | $1.4B | ||
| Q1 24 | $3.8B | $1.4B |
总资产ALGNSEM
| Q4 25 | $6.2B | $5.9B | ||
| Q3 25 | $6.2B | $5.7B | ||
| Q2 25 | $6.2B | $5.7B | ||
| Q1 25 | $6.1B | $5.7B | ||
| Q4 24 | $6.2B | $5.6B | ||
| Q3 24 | $6.4B | $8.0B | ||
| Q2 24 | $6.2B | $7.9B | ||
| Q1 24 | $6.2B | $7.9B |
负债/权益比ALGNSEM
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× | ||
| Q1 24 | — | 2.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $223.2M | $64.3M |
| 自由现金流经营现金流 - 资本支出 | $187.3M | $5.2M |
| 自由现金流率自由现金流/营收 | 17.9% | 0.4% |
| 资本支出强度资本支出/营收 | 3.4% | 4.2% |
| 现金转化率经营现金流/净利润 | 1.64× | 3.19× |
| 过去12个月自由现金流最近4个季度 | $490.8M | $117.2M |
8季度趋势，按日历期对齐
经营现金流ALGNSEM
| Q4 25 | $223.2M | $64.3M | ||
| Q3 25 | $188.7M | $175.3M | ||
| Q2 25 | $128.7M | $110.3M | ||
| Q1 25 | $52.7M | $-3.5M | ||
| Q4 24 | $286.1M | $125.4M | ||
| Q3 24 | $263.7M | $181.0M | ||
| Q2 24 | $159.8M | $278.2M | ||
| Q1 24 | $28.7M | $-66.7M |
自由现金流ALGNSEM
| Q4 25 | $187.3M | $5.2M | ||
| Q3 25 | $169.0M | $122.2M | ||
| Q2 25 | $107.2M | $45.6M | ||
| Q1 25 | $27.4M | $-55.8M | ||
| Q4 24 | $263.1M | $62.0M | ||
| Q3 24 | $233.9M | $130.3M | ||
| Q2 24 | $106.4M | $222.6M | ||
| Q1 24 | $19.3M | $-119.2M |
自由现金流率ALGNSEM
| Q4 25 | 17.9% | 0.4% | ||
| Q3 25 | 17.0% | 9.0% | ||
| Q2 25 | 10.6% | 3.4% | ||
| Q1 25 | 2.8% | -4.1% | ||
| Q4 24 | 26.4% | 4.7% | ||
| Q3 24 | 23.9% | 10.2% | ||
| Q2 24 | 10.3% | 17.4% | ||
| Q1 24 | 1.9% | -9.0% |
资本支出强度ALGNSEM
| Q4 25 | 3.4% | 4.2% | ||
| Q3 25 | 2.0% | 3.9% | ||
| Q2 25 | 2.1% | 4.8% | ||
| Q1 25 | 2.6% | 3.9% | ||
| Q4 24 | 2.3% | 4.8% | ||
| Q3 24 | 3.0% | 4.0% | ||
| Q2 24 | 5.2% | 4.3% | ||
| Q1 24 | 0.9% | 4.0% |
现金转化率ALGNSEM
| Q4 25 | 1.64× | 3.19× | ||
| Q3 25 | 3.33× | 6.09× | ||
| Q2 25 | 1.03× | 2.72× | ||
| Q1 25 | 0.57× | -0.06× | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.27× | 3.25× | ||
| Q2 24 | 1.66× | 3.59× | ||
| Q1 24 | 0.27× | -0.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALGN
暂无分部数据
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
